Top Markets
#1 Geodnet Geodnet +26.56%
#2 XPIN Network XPIN Network +26.30%
#3 Ore Ore +23.54%
#4 Verus Coin Verus Coin +20.48%
#5 The Black Bull The Black Bull +20.33%
#6 AUKI AUKI +18.26%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +16.83%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +16.75%
#9 SSV Network SSV Network +16.67%
#10 Ethena Staked ENA Ethena Staked ENA +16.64%
Coin of the day
Geodnet Geodnet
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Orexo AB Orexo AB

Orexo AB

ORX
Classifica tra le azioni #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Prezzo delle azioni
$1.58
Capitalizzazione di mercato
$55.48M
Variazione (1 giorno)
0.86%
Variazione (1 anno)
-28.33%
Paese
SE
Scambia Orexo AB (ORX)

Categoria

Healthcare
Rapporto P/S per Orexo AB (ORX)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Orexo AB, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Orexo AB da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.29 -
HK